-
Podcast: interview with Dr. Bowman Heiden on role of SEPs in economics, policy intervention, cultivating a transatlantic IP career
Read more: Podcast: interview with Dr. Bowman Heiden on role of SEPs in economics, policy intervention, cultivating a transatlantic IP careerDr. Bowman Heiden is the Executive Director of the Tusher Strategic Initiative for Technology Leadership at UC-Berkeley. He is also the Co-Director of the Center for Intellectual Property (CIP) at the University of Gothenburg, and co-chair of the Technology, Innovation, and Intellectual Property program at the Classical Liberal Institute at the NYU School of Law. …
-
Dyson wins UPC’s first Spanish injunction: first BSH-based preliminary injunction, first BSH injunction based on anchor defendant
Read more: Dyson wins UPC’s first Spanish injunction: first BSH-based preliminary injunction, first BSH injunction based on anchor defendantThe UPC’s Hamburg LD has granted the UPC’s first-ever Spanish injunction, and the Hague LD affirmed, by panel decision, an order in a different case involving non-UPC countries.
-
Federal judge finds Lindis patents unenforceable in leukemia drug dispute, Amgen dodges $50 million payment
Read more: Federal judge finds Lindis patents unenforceable in leukemia drug dispute, Amgen dodges $50 million paymentThe District of Delaware has found two patents asserted in a dispute between Lindis and Amgen over the latter’s leukaemia drug Blincyto “unenforceable due to inequitable conduct”, rendering a prior $50 million jury verdict against Amgen irrelevant.
-
ETRI files HEVC SEP lawsuit against Hisense with UPC shortly after suing Transsion over same patent
Read more: ETRI files HEVC SEP lawsuit against Hisense with UPC shortly after suing Transsion over same patentKorea’s ETRI is now enforcing the same HEVC patent against two different Chinese defendants: smartphone maker Transsion as well as TV maker Hisense.
-
UPC Roundup (1 week): CoA clarifies two key prerequisites to suspension of enforcement; deposit may be used to offset costs; new cases
Read more: UPC Roundup (1 week): CoA clarifies two key prerequisites to suspension of enforcement; deposit may be used to offset costs; new casesThis is a summary of developments in and around the Unified Patent Court (UPC) in the week since our August 10, 2025 UPC Roundup. 1. CoA 1.1 CoA overturns denial of PI based on different take on imminent infringement (Boehringer Ingelheim v. Zentiva) (link to detailed article) The CoA has overturned a Lisbon LD decision that…
-
Donald Trump Jr. owns 5% of patent monetizer Fintiv, his second patent investment to come to light this year (after SIM IP)
Read more: Donald Trump Jr. owns 5% of patent monetizer Fintiv, his second patent investment to come to light this year (after SIM IP)We were first to report on Mr. Trump’s investment in famous patent monetizer Erich Spangenberg’s SIM IP. It turns out he has invested in at least one other patent monetizer.
-
Here’s how Apple is bringing back pulse oxymetry in the U.S. with a workaround that keeps clear of Masimo’s ITC import ban patents
Read more: Here’s how Apple is bringing back pulse oxymetry in the U.S. with a workaround that keeps clear of Masimo’s ITC import ban patentsApple has made headway against Masimo with a clearance decision by U.S. Customs and Border Protection for a designaround.
-
Boehringer wins nintedanib PI against Zentiva as UPC CoA reverses Lisbon LD on when infringement is imminent, clarifies how to argue national law
Read more: Boehringer wins nintedanib PI against Zentiva as UPC CoA reverses Lisbon LD on when infringement is imminent, clarifies how to argue national lawContext: Three months ago, the Unified Patent Court’s (UPC) Lisbon Local Division (LD) denied an application for provisional measures (which in some other jurisdictions would be called a motion for a preliminary injunction (PI)) by Boehringer Ingelheim against Zentiva, holding that an infringement did not appear imminent (item 2 of our May 10, 2025 UPC…


